Back to search

Article

A novel tubulin binding molecule drives differentiation of acute myeloid leukaemia cells

2021-06-03

Abstract excerpt

Acute Myeloid Leukaemia (AML) continues to have a poor prognosis, especially in the elderly. One reason for this is that many treatment regimens are not well tolerated by elderly patients. Much current focus is on the development of therapies that can target specific vulnerabilities of AML while having fewer toxic side effects. However, despite much recent progress in developing better drugs, many patients with AM...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5aa19c5e-a3c6-5d92-bf0b-82aebf2f179b
DOI
10.1101/2021.06.03.446952
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A novel tubulin binding molecule drives differentiation of acute myeloid leukaemia cellsDOI 10.1101/2021.06.03.446952
Select a neighboring publication to make it the new centre.